Literature DB >> 33856258

The validity and reliability of ultra-short-term heart rate variability parameters and the influence of physiological covariates.

Joel S Burma1,2, Sarah Graver1,3, Lauren N Miutz1,4, Alannah Macaulay2, Paige V Copeland2, Jonathan D Smirl1,2.   

Abstract

Ultra-short-term (UST) heart rate variability (HRV) metrics have increasingly been proposed as surrogates for short-term HRV metrics. However, the concurrent validity, within-day reliability, and between-day reliability of UST HRV have yet to be comprehensively documented. Thirty-six adults (18 males, age: 26 ± 5 yr, BMI: 24 ± 3 kg/m2) were recruited. Measures of HRV were quantified in a quiet-stance upright orthostatic position via three-lead electrocardiogram (ADInstruments, FE232 BioAmp). All short-term data recordings were 300 s in length and five UST time points (i.e., 30 s, 60 s, 120 s, 180 s, and 240 s) were extracted from the original 300-s recording. Bland-Altman plots with 95% limits of agreement, repeated measures ANOVA and two-tailed paired t tests demarcated differences between UST and short-term recordings. Linear regressions, coefficient of variation, intraclass correlation coefficients, and other tests examined the validity and reliability in both time- and frequency domains. No group differences were noted between all short-term and UST measures, for either time- (all P > 0.202) or frequency-domain metrics (all P > 0.086). A longer recording duration was associated with augmented validity and reliability, which was less impacted by confounding influences from physiological variables (e.g., respiration rate, carbon dioxide end-tidals, and blood pressure). Conclusively, heart rate, time-domain, and relative frequency-domain HRV metrics were acceptable with recordings greater or equal to 60 s, 240 s, and 300 s, respectively. Future studies employing UST HRV metrics should thoroughly understand the methodological requirements to obtain accurate results. Moreover, a conservative approach should be utilized regarding the minimum acceptable recording duration, which ensures valid/reliable HRV estimates are obtained.NEW & NOTEWORTHY A one size fits all methodological approach to quantify HRV metrics appears to be inappropriate, where study design considerations need to be conducted upon a variable-by-variable basis. The present results found 60 s (heart rate), 240 s (time-domain parameters), and 300 s (relative frequency-domain parameters) were required to obtain accurate and reproducible metrics. The lower validity/reliability of the ultra-short-term metrics was attributable to measurement error and/or confounding from extraneous physiological influences (i.e., respiratory and hemodynamic variables).

Entities:  

Keywords:  autonomic function; heart rate variability; physiological confounding; reliability; validity

Year:  2021        PMID: 33856258     DOI: 10.1152/japplphysiol.00955.2020

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  4 in total

1.  Exploring a Dance/Movement Program on Mental Health and Well-Being in Survivors of Intimate Partner Violence During a Pandemic.

Authors:  Yasemin Özümerzifon; Allison Ross; Tessa Brinza; Gina Gibney; Carol Ewing Garber
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

2.  Reduced heart rate variability is related to the number of metabolic syndrome components and manifest diabetes in the sixth Tromsø study 2007-2008.

Authors:  Naomi Azulay; Roy Bjørkholt Olsen; Christopher Sivert Nielsen; Audun Stubhaug; Trond Geir Jenssen; Henrik Schirmer; Arnoldo Frigessi; Leiv Arne Rosseland; Christian Tronstad
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

3.  Sex differences in autonomic recovery following repeated sinusoidal resistance exercise.

Authors:  Joseph Carere; Joel S Burma; Kailey T Newel; Courtney M Kennedy; Jonathan D Smirl
Journal:  Physiol Rep       Date:  2022-04

4.  The validity and reliability of an open source biosensing board to quantify heart rate variability.

Authors:  Joel S Burma; Andrew P Lapointe; Ateyeh Soroush; Ibukunoluwa K Oni; Jonathan D Smirl; Jeff F Dunn
Journal:  Heliyon       Date:  2021-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.